GUILLAIN-BARRÉ SYNDROME AFTER COVID-19 VACCINATION: A CASE REPORT

• DOI: 10.22533/at.ed.1592116113

• Palavras-chave: Guillain-Barre Syndrome. COVID-19 Vaccines. Nervous System Diseases.

• Keywords: Guillain-Barre Syndrome. COVID-19 Vaccines. Nervous System Diseases

• Abstract:

  Introduction: Guillain-Barré Syndrome (GBS) is an inflammatory, acute demyelinating and autoimmune neurological disease. The appearance of GBS previously associated with several infections, with the advent of the COVID-19 pandemic in early 2020, new cases of SBG emerged as a result of COVID-19 and later after vaccination. Intense research on this correlation has been carried out, but it is difficult to prove the causality of the disease with vaccination, verifying only a temporal relationship. Objective: To report the case of a patient diagnosed with Guillain-Barré Syndrome after vaccination against COVID-19. Method: This is a case report whose data contained in this study were obtained by reviewing the medical record of the patient in question, as well as reports of complementary exams performed by the patient. Discussion and final considerations: In the case in question, the patient presented symptoms suggestive of GBS 30 days after the second dose of Astrazeneca vaccine. No report of clinical or laboratory findings of differential diagnoses that would justify its evolution. Despite occasional case reports in this regard, the National Health Surveillance Agency (ANVISA) maintains the strong recommendation for the continuity of vaccination as it is evident that the benefits are much greater than the risks.

• Número de páginas: 12